About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Pulmonary Pharmacology and Therapeutics
›
Top Articles
Pulmonary Pharmacology and Therapeutics
Pulmonology
,
Pharmacology
,
Biology
,
Biochemistry
3.5
(top 4%)
Impact Factor
3.8
(top 4%)
extended IF
74
(top 5%)
H-Index
1.2K
authors
1.8K
papers
39.2K
citations
3.8K
citing journals
21.4K
citing authors
Most Cited Articles of Pulmonary Pharmacology and Therapeutics
Title
Year
Citations
Reactive oxygen species as mediators in asthma
2001
232
Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review
2007
227
The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD
2010
220
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
2010
220
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway
2008
220
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes
2004
152
The Non-neuronal cholinergic system: an emerging drug target in the airways
2001
148
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic
1999
146
Epidemiology of cough
2002
140
cAMP regulation of airway smooth muscle function
2013
139
Clinical application of forced oscillation
2001
138
Resolvin D1 protects mice from LPS-induced acute lung injury
2011
137
Relationship between neutrophil elastase and acute lung injury in humans
2004
132
Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling
2009
131
Glucocorticoid-regulated transcription factors
2001
130
Molecular mechanisms of glucocorticosteroid actions
2000
126
Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view
2014
125
The inhalers of the future? A review of dry powder devices on the market today
2003
125
Chronic 'cough hypersensitivity syndrome': a more precise label for chronic cough
2011
117
The powerful placebo in cough studies?
2002
117
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD
2004
116
Exploring lung physiology in health and disease with lung slices
2011
115
Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma
2002
115
Markers of disease severity in chronic obstructive pulmonary disease
2006
112
Transforming growth factor-beta and its role in asthma
2003
112
previous
2014
2015
2016
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.